Sign inJoin waitlistJoin the waitlist

Moran Amit

Assistant Professor, Head and Neck Surgery · University of Texas M D Anderson Cancer Center

Credentials: · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

Otolaryngology - Head and Neck Surgery
2016–2021
Faculty of Medicine
2003–2007

Research

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Science · 2021 · 1,371 citations
Immune checkpoint therapy-current perspectives and future directions
Review · Cell · 2023 · 989 citations
Cancer neuroscience: State of the field, emerging directions
Review · Cell · 2023 · 455 citations

Shorook Naara
30 papers · 25 as a resident
Samantha Tam
20 papers · 20 as a resident
Neil Gross
18 papers
SP
Snehal Patel
17 papers
YB
Yoav Binenbaum
17 papers
Jeffrey Myers
16 papers
Ehab Hanna
13 papers
PN
Priyadharsini Nagarajan
13 papers
Michael Migden
12 papers
Jatin Shah
11 papers
Ryan Goepfert
11 papers · 2 as a fellow
Franco DeMonte
10 papers

Grants

Disrupting ATF3/CGRP-IL-6 Neuroimmune Feedback to Overcome Neural Injury–Driven Immunotherapy Resistance in cSCC
National Cancer Institute · R01
Contact PI · $645.9K · University of Tx Md Anderson Can Ctr
2026–2031
Harnessing the Nervous System to Overcome Resistance to Immunotherapy in Oral Cancer
National Institute of Dental and Craniofacial Research · R01
Contact PI · $3.5M · University of Tx Md Anderson Can Ctr
2022–2027
Defining the Role of Tumor-Neutral Crosstalk in Head and Neck Cancer Progression and Treatment Resistance
National Cancer Institute · R37
Contact PI · $3.4M · University of Tx Md Anderson Can Ctr
2020–2027
Cancer Neuroscience: Crossing Disciplines to Revolutionize Cancer Treatment
National Cancer Institute · R13
Contact PI · $10K · University of Tx Md Anderson Can Ctr
2025–2026

Clinical trials

Phase 1 Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cell In Patients With Oral Premalignant Lesions
Principal investigator · Not yet recruiting · Phase 1
M.D. Anderson Cancer Center
2026–2030
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
Principal investigator · Not yet recruiting · Phase 2
M.D. Anderson Cancer Center
2026–2031
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2025–2029
Phase II Randomized, Placebo- Controlled Study of Intralesional Nivolumab for High-risk Oral Premalignant Lesions
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2025–2029